Metabolic dysfunction-associated fatty liver disease exacerbates hematoma expansion in intracerebral hemorrhage: an
Zhuo Yang1, Jie He1, Yong Song2
1Department of Encephalopathy, Chengdu Xinjin District Hospital of Traditional Chinese Medicine, Chengdu, China.
Background:
Although hematoma expansion (HE) severely deteriorates outcomes in hypertensive intracerebral hemorrhage (HICH), predicting HE in patients comorbid with metabolic dysfunction-associated fatty liver disease (MAFLD) lacks specific machine learning tools. This study aimed to bridge this gap by exploring the interactive pathophysiological associations.
Methods:
Data from 529 HICH-MAFLD patients were used to construct five predictive algorithms. The best-performing model was subjected to SHapley Additive exPlanations (SHAP) to map variable interactions.
Results:
The XGBoost model achieved the best discrimination (AUC = 0.911). SHAP analysis revealed non-linear, synergistic statistical associations between the "liver-brain axis" components. Specifically, severe hepatic fibrosis (FIB-4 index) and systemic inflammation (hs-CRP) appeared to exponentially amplify the HE risk associated with local hemodynamic parameters (baseline hematoma volume and systolic blood pressure).
Conclusion:
The SHAP-integrated XGBoost algorithm suggests a robust predictive framework for early HE. The statistical synergy unmasked between metabolic inflammation and local hemodynamics highlights the potential clinical significance of the "liver-brain axis" in guiding individualized risk stratification.
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Hepatic Encephalopathy
